Oncology Pharma Inc. (ONPH)
OTCMKTS · Delayed Price · Currency is USD
0.0480
+0.0130 (37.14%)
At close: Oct 23, 2026
Oncology Pharma Revenue
In the fiscal year ending March 31, 2013, Oncology Pharma had annual revenue of $10.21K, down -92.42%. Oncology Pharma had revenue of $472.31K in the quarter ending December 31, 2011. That makes Oncology Pharma the 47,235th largest company in the world by revenue and 7,178th in the United States.
Revenue
10.21K
Revenue Growth
-98.44%
P/S Ratio
181.70
Revenue / Employee
10.21K
Employees
1
Market Cap
1.86M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2013 | 10.21K | -124.49K | -92.42% |
| Jun 30, 2011 | 134.70K | -1.05M | -88.59% |
| Mar 31, 2004 | 1.18M | -2.10M | -63.99% |
| Mar 31, 2003 | 3.28M | -392.00K | -10.68% |
| Mar 31, 2002 | 3.67M | -340.00K | -8.47% |
| Mar 31, 2001 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2000 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 1999 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 1998 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 1997 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Oncology Pharma News
- 2 years ago - Median Technologies Partners with a Top 10 Oncology Pharma Company to Apply AI for Imaging Biomarker Discovery - Business Wire
- 4 years ago - Oncology Pharma Conducting Interviews and Presentations with Investors to Pursue Next Steps to Forward The Development Process of Nanoemulsion Drug Delivery System - Accesswire
- 4 years ago - Oncology Pharma Conducting All The Preparations to Take Steps to Forward The Development Process of Nanoemulsion Drug Delivery System - Accesswire
- 4 years ago - Oncology Pharma Announces: Initial Feasibility Study of the Nanoemulsion Drug Delivery System is Complete and Results Have Met the Threshold for Moving Forward To the Next Steps of Development - Accesswire
- 4 years ago - Oncology Pharma Advances Progress on Multiple Fronts Including Advanced Attention to Connect2Trials' Commercial Development - Accesswire
- 4 years ago - Oncology Pharma Completes Feasibility Phase of its Licensed Nanoemulsion Drug Delivery System to Treat Cancer - Accesswire
- 4 years ago - Oncology Pharma Reports on Progress with Ribera Solutions - Accesswire
- 4 years ago - Oncology Pharma Releases Further Feasibility Studies, Data and Capacities - Accesswire